# DABIGATRAN ETEXILATE MESYLATE
> **ANDA207922** · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2024-12-19
## Drug
- **FDA Application Number:** ANDA207922
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DABIGATRAN ETEXILATE MESYLATE
- **Generic name:** Dabigatran Etexilate Mesylate
- **Active ingredients:** DABIGATRAN ETEXILATE MESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** BRECKENRIDGE
- **First approval:** 2024-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207922)
---
*AI Analytics · CC0 1.0*